Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.9 USD | -0.02% | -1.52% | -3.79% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.74B | Capitalization | 184B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.18B | EV / Sales 2024 * | 4.55 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 640M | EV / Sales 2025 * | 4.1 x |
P/E ratio 2024 * |
31
x | P/E ratio 2025 * |
26.4
x | Employees | 114,000 |
Yield 2024 * |
2.05% | Yield 2025 * |
2.19% | Free-Float | 86.73% |
Latest transcript on Abbott Laboratories
1 day | -0.02% | ||
1 week | -1.52% | ||
Current month | -0.07% | ||
1 month | -4.77% | ||
3 months | -5.15% | ||
6 months | +10.50% | ||
Current year | -3.79% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +3.01% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 105.9 | -0.02% | 3,610,492 |
24-05-02 | 105.9 | -0.35% | 3,708,515 |
24-05-01 | 106.3 | +0.30% | 4,097,108 |
24-04-30 | 106 | -1.21% | 5,073,971 |
24-04-29 | 107.3 | -0.24% | 3,307,022 |
Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B | |
-0.03% | 25.03B |
- Stock Market
- Equities
- ABT Stock